Label: AGRIMYCIN 200- oxytetracycline injection

  • NDC Code(s): 23243-7430-4, 23243-7430-5, 23243-7430-6
  • Packager: Huvepharma Inc
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Animal Drug Application

Drug Label Information

Updated March 19, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

                                        AGRIMYCIN® 200
                                 (oxytetracycline injection)

                                               Antibiotic

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Each mL contains 200 mg of oxytetracycline base as oxytetracycline dihydrate.

    For the treatment of disease in beef cattle; dairy cattle; calves, including preruminating
    (veal) calves; and swine 

                                     For animal use only 
                         Approved by FDA under ANADA # 200-128

  • DESCRIPTION

    AGRIMYCIN® 200 (oxytetracycline injection) is a sterile, preconstituted
    solution of the broad-spectrum antibiotic oxytetracycline. Each mL
    contains 200 mg of oxytetracycline base as oxytetracycline dihydrate,
    and on a w/v basis, 40.0% 2-pyrrolidone, 5.0% povidone, 1.8%
    magnesium oxide, 0.2% sodium formaldehyde sulfoxylate (as a
    preservative), monoethanolamine and/or hydrochloric acid as
    required to adjust pH.

  • WARNINGS AND PRECAUTIONS

    CAUTION: When administered to cattle, muscle discoloration may
    necessitate trimming of the injection site(s) and surrounding tissues
    during the dressing procedure.

    Warnings: Discontinue treatment at least 28 days prior
    to slaughter of cattle and swine. Milk taken from animals
    during treatment and for 96 hours after the last treatment
    must not be used for food.

    Precautions: Exceeding the highest recommended level of drug per lb
    of body weight per day, administering more than the recommended
    number of treatments, and/or exceeding 10 mL subcutaneously per
    injection site in adult beef and dairy cattle, and 5 mL intramuscularly
    per injection site in adult swine, may result in antibiotic residues
    beyond the withdrawal period.

  • SPL UNCLASSIFIED SECTION

    ® Registered Trademark of Huvepharma, Inc.
    Manufactured for Huvepharma, Inc., Peachtree City, GA 30269

    Take Time

    LOT NO.:                                              EXP. DATE:

  • DOSAGE & ADMINISTRATION

    Dosage: Cattle: A single dosage of 9 mg of oxytetracycline per lb
    of body weight (4.5 mL/100 lb) administered subcutaneously is
    recommended in the treatment of the following conditions:
    1) bacterial pneumonia caused by Pasteurella spp. (shipping fever)
    in calves and yearlings, where retreatment is impractical due to
    husbandry conditions, such as cattle on range, or where repeated
    restraint is inadvisable; 2) infectious bovine keratoconjunctivitis
    (pinkeye) caused by Moraxella bovis.

    Swine: A single dosage of 9 mg of oxytetracycline per lb of body
    weight (4.5 mL/100 lb) administered intramuscularly is recommended
    in the treatment of bacterial pneumonia caused by Pasteurella
    multocida in swine, where retreatment is impractical due to husbandry
    conditions or where repeated restraint is inadvisable.

    Refer to Package Onsert for Complete Directions.

  • HOW SUPPLIED

    How Supplied: AGRIMYCIN® 200 is available in 100 mL, 250 mL and
    500 mL multi-dose amber vials.

  • STORAGE AND HANDLING

    Storage: Store at room temperature 15°-25°C
    (59°-77°F). Keep from freezing. Use within 12
    months of first puncture. Puncture a maximum
    of 100 times.

    Not For Human Use

  • SPL UNCLASSIFIED SECTION

                                  AGRIMYCIN® 200
                            (oxytetracycline injection)

                                         Antibiotic

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Each mL contains 200 mg of oxytetracycline base as oxytetracycline dihydrate.

    For the treatment of diseases in beef cattle; dairy cattle; calves, including
    preruminating (veal) calves; and swine

                                    For animal use only

                   Read Entire Package Onsert Carefully Before
                                     Using This Product.

  • DESCRIPTION

    AGRIMYCIN® 200 (oxytetracycline injection) is a sterile,
    ready-to-use solution for the administration of the
    broad-spectrum antibiotic oxytetracycline by injection.

    AGRIMYCIN® 200 administered to cattle or swine for the
    treatment of bacterial pneumonia at a dosage of 9 mg of
    oxytetracycline per lb of body weight has been demonstrated
    in clinical trials to be as effective as 2 or 3 repeated, daily
    treatments of oxytetracycline injectable at 3-5 mg/lb of body
    weight.

    AGRIMYCIN® 200 does not require refrigeration; however, it is
    recommended that it be stored at room temperature, 15º-25ºC
    (59º-77ºF). The antibiotic activity of oxytetracycline is not
    appreciably diminished in the presence of body fluids, serum,
    or exudates.

  • WARNINGS AND PRECAUTIONS

    CAUTION: When administered to cattle, muscle discoloration may necessitate trimming of the
    injection site(s) and surrounding tissues during the dressing procedure.

    WARNINGS: Discontinue treatment at least 28 days prior to slaughter of cattle and swine. Milk
    taken from animals during treatment and for 96 hours after the last treatment must not be used
    for food. Rapid intravenous administration may result in animal collapse.

    Oxytetracycline should be administered intravenously slowly over a period of at least 5 minutes.

    PRECAUTIONS: Exceeding the highest recommended dosage level of drug per lb of body weight per
    day, administering more than the recommended number of treatments, and/or exceeding 10 mL
    subcutaneously per injection site in adult beef and dairy cattle, and 5 mL intramuscularly per
    injection site in adult swine, may result in antibiotic residues beyond the withdrawal period.

    At the first sign of any adverse reaction, discontinue use of the product and seek the advice of
    your veterinarian. Some of the reactions may be attributed either to anaphylaxis (an allergic
    reaction) or to cardiovascular collapse of unknown cause.

    Shortly after injection, treated animals may have transient hemoglobinuria resulting in darkened
    urine.

    As with all antibiotic preparations, use of this drug may result in overgrowth of non-susceptible
    organisms, including fungi. A lack of response by the treated animal, or the development of new
    signs, may suggest that an overgrowth of nonsusceptible organisms has occurred. If any of these
    conditions occur, consult your veterinarian.

    Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable
    to avoid giving AGRIMYCIN® 200 in conjunction with penicillin.

  • ADVERSE REACTIONS

    ADVERSE REACTIONS: Reports of adverse reactions associated with oxytetracycline administration include 
    injection site swelling, restlessness, ataxia, trembling, swelling of eyelids, ears, muzzle, anus and vulva (or 
    scrotum and sheath in males), respiratory abnormalities (labored breathing), frothing at the mouth, collapse 
    and possibly death. Some of these reactions may be attributed to anaphylaxis (an allergic reaction) or to 
    cardiovascular collapse of unknown cause.

  • STORAGE AND HANDLING

    STORAGE: Store at room temperature 15°-25°C (59°-77°F).
    Keep from freezing. Use within 12 months of first puncture.
    Puncture a maximum of 100 times.

  • INFORMATION FOR OWNERS/CAREGIVERS

    CARE OF SICK ANIMALS: The use of antibiotics in the management of diseases is based on
    an accurate diagnosis and an adequate course of treatment. When properly used in the
    treatment of diseases caused by oxytetracycline susceptible organisms, most animals
    that have been treated with AGRIMYCIN® 200 show a noticeable improvement within 24-48
    hours.

  • INDICATIONS & USAGE

    INDICATIONS: AGRIMYCIN® 200 is intended for use in the treatment of the following
    diseases in beef cattle; dairy cattle; calves, including preruminating (veal)
    calves; and swine when due to oxytetracycline-susceptible organisms:

    Cattle: AGRIMYCIN® 200 is indicated in the treatment of pneumonia and shipping
    fever complex associated with Pasteurella spp. and Haemophilus spp; infectious
    bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis; foot rot and
    diphtheria caused by Fusobacterium necrophorum; bacterial enteritis (scours)
    caused by Escherichia coli; wooden tongue caused by Actinobacillus lignieresii;
    leptospirosis caused by Leptospira pomona; and wound infections and acute metritis
    caused by strains of staphylococci and streptococci organisms sensitive to
    oxytetracycline.

    Swine: AGRIMYCIN® 200 is indicated in the treatment of bacterial enteritis (scours,
    colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella multocida;
    and leptospirosis caused by Leptospira pomona.

    In sows, AGRIMYCIN® 200 is indicated as an aid in the control of infectious enteritis
    (baby pig scours, colibacillosis) in suckling pigs caused by Escherichia coli.

  • DOSAGE & ADMINISTRATION

    DOSAGE:

    Cattle: AGRIMYCIN® 200 is to be administered by subcutaneous (SC, under
    the skin) or intravenous injection according to Beef Quality Assurance
    Guidelines.

    A single dosage of 9 mg of AGRIMYCIN® 200 per lb of body weight administered
    subcutaneously is recommended in the treatment of the following conditions:
    1) bacterial pneumonia caused by Pasteurella spp. (shipping fever) in calves
    and yearlings, where retreatment is impractical due to husbandry conditions,
    such as cattle on range, or where their repeated restraint is inadvisable;
    2) infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis.

    AGRIMYCIN® 200 can also be administered by subcutaneous or intravenous injection
    at a level of 3-5 mg of oxytetracycline per lb of body weight per day. In the
    treatment of severe foot rot and advanced cases of other indicated diseases, a
    dosage level of 5 mg/lb of body weight per day is recommended.
    Treatment should be continued 24-48 hours following remission of disease signs;
    however, not to exceed a total of 4 consecutive days. Consult your veterinarian
    if improvement is not noted within 24-48 hours of the beginning of treatment.

    Swine: A single dosage of 9 mg of AGRIMYCIN® 200 per lb of body weight
    administered intramuscularly in the neck region is recommended in the treatment
    of bacterial pneumonia caused by Pasteurella multocida in swine, where retreatment
    is impractical due to husbandry conditions or where repeated restraint is
    inadvisable.

    AGRIMYCIN® 200 can also be administered by intramuscular injection at a level of
    3-5 mg of oxytetracycline per lb of body weight per day. Treatment should be
    continued 24-48 hours following remission of disease signs; however, not to
    exceed a total of 4 consecutive days. Consult your veterinarian if improvement
    is not noted within 24-48 hours of the beginning of treatment.

    For sows, administer once intramuscularly in the neck region 3 mg of oxytetracycline
    per lb of body weight approximately 8 hours before farrowing or immediately after
    completion of farrowing.

    For swine weighing 25 lb of body weight and under, AGRIMYCIN® 200 should be
    administered undiluted for treatment at 9 mg/lb but should be administered diluted
    for treatment at 3 or 5 mg/lb.

    Volume

    * To prepare dilution, add 1 part AGRIMYCIN® 200 to 3, 5 or 7 parts of sterile water,
    or 5% dextrose solution as indicated; the diluted product should be used immediately.

  • INSTRUCTIONS FOR USE

    DIRECTIONS FOR USE: AGRIMYCIN® 200 is intended for use in the treatment of
    disease due to oxytetracycline-susceptible organisms in beef cattle; dairy
    cattle; calves, including preruminating (veal) calves; and swine. A thoroughly
    cleaned, sterile needle and syringe should be used for each injection (needles
    and syringes may be sterilized by boiling in water for 15 minutes). In cold
    weather, AGRIMYCIN® 200 should be warmed to room temperature before administration
    to animals. Before withdrawing the solution from the bottle, disinfect the rubber
    cap on the bottle with suitable disinfectant, such as 70% alcohol. The injection
    site should be similarly cleaned with the disinfectant. Needles of 16-18 gauge and
    1-1/2 inches long are adequate for intramuscular and subcutaneous injections.
    Needles 2-3 inches are recommended for intravenous use.

    Intramuscular Administration:

    Intramuscular injections in swine should be made by directing the needle of suitable
    gauge and length into the fleshy part of a thick muscle in the neck region; avoid
    blood vessels and major nerves. Before injecting the solution, pull back gently on
    the plunger. If blood appears in the syringe, a blood vessel has been entered;
    withdraw the needle and select a different site. No more than 5 mL should be injected
    at any one site in adult swine; rotate injection sites for each succeeding treatment.

    Subcutaneous Administration:
    Subcutaneous injections in beef cattle, dairy cattle, and calves, including
    preruminating (veal) calves, should be made by directing the needle of suitable
    gauge and length through the loose folds of the neck skin in front of the shoulder.
    Care should be taken to ensure that the tip of the needle has penetrated the skin
    but is not lodged in muscle. Before injecting the solution, pull back gently on the
    plunger. If blood appears in the syringe, a blood vessel has been entered; withdraw
    the needle and select a different site. The solution should be injected slowly into
    the area between the skin and muscles. No more than 10 mL should be injected
    subcutaneously at any one site in adult beef and dairy cattle; rotate injection
    sites for each succeeding treatment. The volume administered per injection site
    should be reduced according to age and body size so that 1-2 mL per site is injected
    in small calves.

    Intravenous Administration:
    AGRIMYCIN® 200 may be administered intravenously to beef and dairy cattle. As with all
    highly concentrated materials, AGRIMYCIN® 200 should be administered slowly by the
    intravenous route.

    Preparation of the Animal for Injection:
    1. Approximate location of vein. The jugular vein runs in the jugular groove on each
    side of the neck from the angle of the jaw to just above the brisket and slightly
    above and to the side of the windpipe. (See Fig. I) 

    2. Restraint. A stanchion or chute is ideal for restraining the animal. With a halter,
    rope, or cattle leader (nose tongs), pull the animal's head around the side of the
    stanchion, cattle chute, or post in such a manner to form a bow in the neck (See Fig. II),
    then snub the head securely to prevent movement. By forming the bow in the neck,
    the outside curvature of the bow tends to expose the jugular vein and make it easily
    accessible.

    Caution: Avoid restraining the animal with a tight rope or halter around the throat or
    upper neck which might impede blood flow. Animals that are down present no problem so far
    as restraint is concerned.

    3. Clip hair in area where injection is to be made (over the vein in the upper third of
    the neck). Clean and disinfect the skin with alcohol or other suitable antiseptic.

    Injection Site

    Entering the Vein and Making the Injection:
    1. Raise the vein. This is accomplished by tying the choke rope tightly around the neck close
    to the shoulder. The rope should be tied in such a way that it will not come loose and so that
    it can be untied quickly by pulling the loose end (See Fig. II). In thick-necked animals, a
    block of wood placed in the jugular groove between the rope and the hide will help considerably
    in applying the desired pressure at the right point. The vein is a soft flexible tube through
    which blood flows back to the heart. Under ordinary conditions it cannot be seen or felt with
    the fingers. When the flow of blood is blocked at the base of the neck by the choke rope, the
    vein becomes enlarged and rigid because of the back pressure. If the choke rope is sufficiently
    tight, the vein stands out and can be easily seen and felt in thin-necked animals. As a further
    check in identifying the vein, tap it with the fingers in front of the choke rope. Pulsations
    that can be seen or felt with the fingers in front of the point being tapped will confirm the
    fact that the vein is properly distended. It is impossible to put the needle into the vein
    unless it is distended. Experienced operators are able to raise the vein simply by hand pressure,
    but the use of a choke rope is more certain. 

    2. Inserting the needle. This involves 3 distinct steps. First, insert the needle through the hide.
    Second, insert the needle into the vein. This may require 2 or 3 attempts before the vein is entered.
    The vein has a tendency to roll away from the point of the needle, especially if the needle is not
    sharp. The vein can be steadied with the thumb and finger of one hand. With the other hand, the needle
    point is placed directly over the vein, slanting it so that its direction is along the length of the
    vein, either toward the head or toward the heart. Properly positioned this way, a quick thrust of the
    needle will be followed by a spurt of blood through the needle, which indicates that the vein has been
    entered. Third, once in the vein, the needle should be inserted along the length of the vein all the
    way to the hub, exercising caution to see that the needle does not penetrate the opposite side of the
    vein. Continuous steady flow of blood through the needle indicates that the needle is still in the vein.
    If blood does not flow continuously, the needle is out of the vein (or clogged) and another attempt
    must be made. If difficulty is encountered, it may be advisable to use the vein on the other side of
    the neck. 

    3. While the needle is being placed in proper position in the vein, an assistant should get the
    medication ready so that the injection can be started without delay after the vein has been entered.

    4. Making the injection. With the needle in position as indicated by continuous flow of blood, release
    the choke rope by a quick pull on the free end. This is essential - the medication cannot flow into
    the vein while it is blocked. Immediately connect the syringe containing AGRIMYCIN® 200 to the needle
    and slowly depress the plunger. If there is resistance to depression of the plunger, this indicates
    that the needle has slipped out of the vein (or is clogged) and the procedure will have to be
    repeated. Watch for any swelling under the skin near the needle, which would indicate that the medication
    is not going into the vein. Should this occur, it is best to try the vein on the opposite side of the neck.

    5. Removing the needle. When injection is complete, remove needle with straight pull. Then apply pressure
    over area of injection momentarily to control any bleeding through needle puncture, using cotton soaked
    in alcohol or other suitable antiseptic.

  • SPL UNCLASSIFIED SECTION

    Not For Human Use
    Approved by FDA under ANADA # 200-128

    Take Time 2

    Manufactured for Huvepharma, Inc., Peachtree City, GA 30269

  • DOSAGE & ADMINISTRATION

    Dosage: Cattle: A single dosage of 9 mg of oxytetracycline per lb of body weight
    (4.5 mL/100 lb) administered subcutaneously is recommended in the treatment of
    the following conditions: 1) bacterial pneumonia caused by Pasteurella spp.
    (shipping fever) in calves and yearlings, where retreatment is impractical
    due to husbandry conditions, such as cattle on range, or where repeated
    restraint is inadvisable; 2) infectious bovine keratoconjunctivitis (pinkeye)
    caused by Moraxella bovis.

    Swine: A single dosage of 9 mg of oxytetracycline per lb of body weight
    (4.5 mL/100 lb) administered intramuscularly is recommended in the treatment
    of bacterial pneumonia caused by Pasteurella multocida in swine, where retreatment
    is impractical due to husbandry conditions or where repeated restraint is
    inadvisable.

    Refer to Package Onsert for Complete Directions.

  • HOW SUPPLIED

    How Supplied: AGRIMYCIN® 200 is available in 100 mL,
    250 mL and 500 mL multi-dose amber vials.

  • STORAGE AND HANDLING

    Storage: Store at room temperature
    15°-25°C (59°-77°F). Keep from
    freezing. Use within 12 months of first
    puncture. Puncture a maximum of 100
    times.

    Not For Human Use

  • PRINCIPAL DISPLAY PANEL

    500 mL Vial Label SH

    500 mL Onsert SH 1-3

    500 mL Onsert SH 4-9

    500 mL Onsert SH 10-12

    500 mL CT SH

  • INGREDIENTS AND APPEARANCE
    AGRIMYCIN  200
    oxytetracycline injection
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:23243-7430
    Route of AdministrationSUBCUTANEOUS, INTRAMUSCULAR, INTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OXYTETRACYCLINE (UNII: X20I9EN955) (OXYTETRACYCLINE ANHYDROUS - UNII:SLF0D9077S) OXYTETRACYCLINE200 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    PYRROLIDONE (UNII: KKL5D39EOL)  
    SODIUM FORMALDEHYDE SULFOXYLATE (UNII: X4ZGP7K714)  
    POVIDONE (UNII: FZ989GH94E)  
    MAGNESIUM OXIDE (UNII: 3A3U0GI71G)  
    Water (UNII: 059QF0KO0R)  
    Hydrochloric acid (UNII: QTT17582CB)  
    Monoethanolamine (UNII: 5KV86114PT)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:23243-7430-4100 mL in 1 VIAL
    2NDC:23243-7430-5250 mL in 1 VIAL
    3NDC:23243-7430-6500 mL in 1 VIAL
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANADAANADA20012809/01/2016
    Labeler - Huvepharma Inc (619153559)